Patent details

EP3337467 Title: COMBINATION THERAPY USING LIPOSOMAL IRINOTECAN AND A PARP INHIBITOR FOR CANCER TREATMENT

Basic Information

Publication number:
EP3337467
PCT Application Number:
US2016047814
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP167574987
PCT Publication Number:
WO2017031442
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION THERAPY USING LIPOSOMAL IRINOTECAN AND A PARP INHIBITOR FOR CANCER TREATMENT
French Title of Invention:
POLYTHÉRAPIE UTILISANT L'IRINOTÉCAN LIPOSOMAL ET UN INHIBITEUR DE PARP POUR LE TRAITEMENT DU CANCER
German Title of Invention:
KOMBINATIONSTHERAPIE UNTER VERWENDUNG VON LIPOSOMALEM IRINOTECAN UND EINEM PARP-HEMMER ZUR BEHANDLUNG VON KREBS
SPC Number:

Dates

Filing date:
19/08/2016
Grant date:
09/12/2020
EP Publication Date:
27/06/2018
PCT Publication Date:
23/02/2017
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/12/2020
EP B1 Publication Date:
09/12/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
19/08/2036
Renunciation date:
Revocation date:
05/05/2023
Annulment date:

Owner

From:
02/12/2020
 
 

Name:
Ipsen Biopharm Ltd.
Address:
Ash Road, Wrexham Industrial Estate Wrexham LL13 9UF, United Kingdom (GB)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
15/12/2020
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
MOYO, Victor
Address:
United States (US)

2

Name:
DRUMMOND, Daryl, C.
Address:
United States (US)

3

Name:
FITZGERALD, Jonathan, Basil
Address:
United States (US)

4

Name:
BLANCHETTE, Sarah, F.
Address:
United States (US)

Priority

1

Priority Number:
201562207760 P
Priority Date:
20/08/2015
Priority Country:
United States (US)

2

Priority Number:
201562207709 P
Priority Date:
20/08/2015
Priority Country:
United States (US)

3

Priority Number:
201562269511 P
Priority Date:
18/12/2015
Priority Country:
United States (US)

4

Priority Number:
201562269756 P
Priority Date:
18/12/2015
Priority Country:
United States (US)

5

Priority Number:
201662308924 P
Priority Date:
16/03/2016
Priority Country:
United States (US)

6

Priority Number:
201662323422 P
Priority Date:
15/04/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/127; A61K 31/04; A61K 31/166; A61K 31/416; A61K 31/4184; A61K 31/436; A61K 31/4745; A61K 31/475; A61K 31/502; A61K 31/55; A61K 47/06; A61P 35/00;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2023/11
Publication date:
05/10/2023
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:
202050
Publication date:
09/12/2020
Description:
Grant (B1)

2

Issue number:
202141
Publication date:
13/10/2021
Description:
Opposition procedure started

3

Issue number:
202337
Publication date:
13/09/2023
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
16/08/2022
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
15/12/2020 Outgoing Correspondence 1
15/12/2020 Power Of Attorney 1